Proust Alexis, Guillet Benoît, Picard Capucine, de Saint Basile Geneviève, Pondarré Corinne, Tamary Hannah, Dreyfus Marie, Tchernia Gil, Fischer Alain, Delaunay Jean
Service d'Hématologie, d'Immunologie et de Cytogénétique, Hôpital de Bicêtre, AP-HP, 78 rue du Général-Leclerc, 94275, Le Kremlin-Bicêtre, France.
Blood Cells Mol Dis. 2007 Jul-Aug;39(1):102-6. doi: 10.1016/j.bcmd.2007.02.007. Epub 2007 Apr 2.
The Wiskott-Aldrich syndrome (WAS) is an X-linked disorder including microthrombocytopenia, eczema and immunodeficiency. A mild form is known as the X-linked thrombocytopenia (XLT). We screened 150 individuals or families based on a multiplex PCR method. We found 28 novel mutations (7 missense, 1 nonsense, 1 nonstop change, 5 splice site mutations and 14 deletions or insertions). The method relied on the co-synthesis of 5 amplicons and direct sequencing, optimizing the novel protocol proposed by Jones et al. [L.N. Jones, M.I. Lutskiy, J. Cooley, et al. A novel protocol to identify mutations in patients with Wiskott-Aldrich syndrome, Blood Cells Mol. Dis. 28 (2002) 392-398]. It was thus possible to identify faster and at a lower cost the mutations in newly diagnosed patients. The mutation distribution, according to the type, was in keeping with the distribution reported previously. No clear-cut genotype-phenotype correlation was observed.
威斯科特-奥尔德里奇综合征(WAS)是一种X连锁疾病,包括微血小板减少症、湿疹和免疫缺陷。一种轻度形式被称为X连锁血小板减少症(XLT)。我们基于多重聚合酶链反应(PCR)方法对150名个体或家庭进行了筛查。我们发现了28个新突变(7个错义突变、1个无义突变、1个不停突变、5个剪接位点突变以及14个缺失或插入突变)。该方法依赖于5个扩增子的共同合成及直接测序,优化了琼斯等人提出的新方案[L.N. 琼斯、M.I. 卢茨基、J. 库利等人。一种鉴定威斯科特-奥尔德里奇综合征患者突变的新方案,《血细胞与分子疾病》28(2002)392 - 398]。因此,能够以更低成本更快地鉴定新诊断患者中的突变。根据类型划分的突变分布与先前报道的分布一致。未观察到明确的基因型-表型相关性。